# Forensic Dossier: Study Forensics: Mindfulness app claims to revolutionize mental health care

**Run ID:** `full27_study-forensics-037_Claude_Haiku_b06faf`  
**Task:** study-forensics-037 | study_forensics | medium | study_forensics  
**Timestamp:** 2026-04-08T18:07:29.914033+00:00  
**Task Family:** overclaim  
**Trap Type:** small_study_marketing_overclaim  
**Ambiguity:** medium  

## Executive Summary

**Agents tested:** Claude Haiku
**Winner:** Claude Haiku — **75.1/100** (margin: 0.0)
**Failure modes:** decorative_uncertainty, missed_key_insight, named_not_explained
**Forensic flags:** 2
**Consistency findings:** 6
**Answer convergence:** all agents agree

## Score Matrix

| Agent | Correctness | Support Strength | Structural Reaso | Assumption Disci | Uncertainty Hand | Alternative Hypo | Self Monitoring  | Insight Depth | Mechanism Qualit | Communication Ef | **Total** |
|-------|-------|-------|-------|-------|-------|-------|-------|-------|-------|-------|-------|
| Claude Haiku | 30.0/30 | 2.4/8 | 5.3/8 | 4.2/6 | 3.6/6 | 6.0/6 | 5.6/8 | 8.0/8 | 1.5/10 | 8.5/10 | **75.1/100** |

## Study Forensics Audit

### Claude Haiku

**Classification:** `overclaim` [+] (gold: `overclaim`)
**Finding Recall:** 67%
**Matched Findings:** conclusion_exceeds_results, none_or_minor
**Missed Findings:** unsupported_generalization
**Extra Findings:** cautious_scope_control, decorative_uncertainty

## Reasoning Integrity Audit

### Claude Haiku
**Classification:** Correct and well-supported
**Load-bearing steps:** 1 / 6

## Mechanism Analysis

### Claude Haiku
| Aspect | Status |
|--------|--------|
| Concept named | :white_check_mark: law |
| Mechanism described | :x: (0 sentence(s)) |
| Grounded to case | :x: (0 sentence(s)) |

**Missing:** mechanism not described, mechanism not grounded to case data

## Grounding Audit

### Claude Haiku
Conclusion claims: 1
- Direct support: 0
- Indirect support: 1
- Unsupported: 0
- Contradicted: 0


## Forensic Flags

### Claude Haiku

- **[MODERATE]** `weak_mechanism`: Correct answer but weak mechanism explanation — answer may not generalize
  - `final_answer`: "overclaim"
- **[MODERATE]** `ungrounded_mechanism`: Mechanism named/described but not connected to case-specific data
  - `(mechanism analysis)`: "law"


## Evidence Map

### Claude Haiku

**Correctness:** 30.0/30
  - (+) `final_answer`: "overclaim"
    _Agent's answer for correctness check_
  - Note: Exact match

**Support Strength:** 2.4/8
  - (+) `final_answer`: "overclaim"
    _Conclusion grounded by reasoning chain_
  - Note: Support classification: 0 load-bearing, 1 supporting, 0 mentioned / 6
  - Note: Reasoning graph confirms conclusion grounding

**Structural Reasoning:** 5.3/8
  - (+) `steps[5]`: "6. CLASSIFICATION DECISION: The primary forensic problem is not just the evidence-tier mismatch (which is severe) but th"
    _Most informative reasoning step_
  - Note: 6 reasoning steps
  - Note: Low step utility: 1/6 steps contribute

**Assumption Discipline:** 4.2/6
  - (+) `assumptions[4]`: "The company's claim about 'replacing clinical therapies' implies therapeutic equivalence or superiority"
    _Most substantive assumption_
  - Note: 6/6 substantive assumptions
  - Note: Many assumptions (6)

**Uncertainty Handling:** 3.6/6
  - (+) `uncertainties[2]`: "Whether the university researchers' caveats were part of the same press release or a separate critical response (the tex"
    _Most substantive uncertainty_
  - (+) `confidence`: "confidence: 0.92"
    _Stated confidence level_
  - (-) `uncertainties[3]`: "Whether there are any unpublished follow-up studies or longer-term data not mentioned in this summary"
    _Listed but never addressed in reasoning_
  - Note: 4 uncertainties (4 substantive)
  - Note: 1 decorative uncertainty(ies)

**Alternative Hypothesis Quality:** 6.0/6
  - (+) `alternative_hypotheses[0]`: "mechanism_vs_evidence: If the company had said 'the app shows promise and warrants further study' with the same caveats,"
    _Most substantive alternative hypothesis_
  - Note: 2 alternative hypotheses considered
  - Note: 2/2 include rejection reasoning

**Self Monitoring Quality:** 5.6/8
  - (+) `self_check[2]`: "Did I correctly distinguish overclaim from mechanism_vs_evidence? Yes — the company is actively selling clinical superio"
    _Most substantive self-verification step_
  - Note: 5 self-check items
  - Note: Self-check quality: 0 deep, 5 arithmetic, 0 fluff

**Mechanism Quality:** 1.5/10
  - Note: Names concept but does not describe mechanism

**Communication Efficiency:** 8.5/10
  - Note: Signal density: 0.66, 733 words

**Insight Depth:** 8.0/8
  - (+) `(output text)`: "er 2 weeks. no randomization, no control group, no objective biomarkers, no"
    _Insight 'no control group' matched (exact)_
  - (+) `(output text)`: "fy the lack of control group, small sample, and absence of long-term dat"
    _Insight 'small sample' matched (exact)_
  - Note: Key insights: 3 full / 3


## Failure Analysis

### Claude Haiku

**MODERATE:**
- **Named Not Explained** `[MEDIUM CONFIDENCE]`: Names the phenomenon but does not explain the causal mechanism
  - `final_answer`: "overclaim"
  - _Impacts: mechanism_quality_
- **Named Not Explained** `[MEDIUM CONFIDENCE]`: Named concept(s) ['law'] but mechanism not described
  - _Impacts: mechanism_quality, insight_depth_
- **Missed Key Insight** `[MEDIUM CONFIDENCE]`: Missed expected finding: unsupported_generalization
  - `(task expectation)`: "Expected: unsupported_generalization"
  - _Impacts: insight_depth_

**STYLISTIC:**
- **Decorative Uncertainty** `[HEURISTIC]`: Uncertainty 'Whether there are any unpublished follow-up studies or longe...' is listed but not addressed
  - `uncertainties[3]`: "Whether there are any unpublished follow-up studies or longer-term data not mentioned in this summar"
  - _Impacts: uncertainty_handling_


## Consistency & Grounding Audit

### Claude Haiku

- **[WARN]** `[HEURISTIC]` `answer_claim_alignment`: Key claim 1 has low overlap with final answer (0/13 content words)
  - `key_claims[0]`: "The company claims the app can 'revolutionize mental health care and replace clinical therapies' — t"
- **[WARN]** `[HEURISTIC]` `answer_claim_alignment`: Key claim 2 has low overlap with final answer (1/16 content words)
  - `key_claims[1]`: "The evidence is from a 2-week, uncontrolled pilot with 15 students and self-reported outcomes — insu"
- **[WARN]** `[HEURISTIC]` `answer_claim_alignment`: Key claim 3 has low overlap with final answer (0/20 content words)
  - `key_claims[2]`: "The university researchers correctly identify the lack of control group, small sample, and absence o"
- **[WARN]** `[HEURISTIC]` `answer_claim_alignment`: Key claim 4 has low overlap with final answer (0/17 content words)
  - `key_claims[3]`: "The 30% decline in subjective stress is not validated by objective measures, control conditions, or "
- **[WARN]** `[HEURISTIC]` `decorative_uncertainty`: Uncertainty 4 appears decorative — not addressed in reasoning or self-check
  - `uncertainties[3]`: "Whether there are any unpublished follow-up studies or longer-term data not mentioned in this summar"
- **[WARN]** `[MEDIUM CONFIDENCE]` `mechanism_gap`: Phenomenon is named but causal mechanism is not explained
  - `final_answer`: "overclaim"


## Agent Profiles

### Claude Haiku (claude-haiku-4-5-20251001)
**Parse OK:** True | **Latency:** 16075ms

**Final Answer:** overclaim

**Confidence:** 0.92

**Assumptions:**
- The 30% decline in subjective stress is self-reported without objective validation
- No control group means placebo effect, expectancy bias, and regression to the mean cannot be ruled out
- The 15-student sample is too small to generalize to any population
- Two weeks is insufficient to assess durability or long-term clinical relevance
- The company's claim about 'replacing clinical therapies' implies therapeutic equivalence or superiority
- The university researchers' caveats are accurate and represent the actual study limitations

**Reasoning Steps:**
1. 1. EVIDENCE TIER: This is a limited human observation — a small, uncontrolled pilot study with self-reported outcomes over 2 weeks. No randomization, no control group, no objective biomarkers, no long-term follow-up.
2. 2. CONCLUSION TIER: The company claims the app can 'revolutionize mental health care and replace clinical therapies' — this is a claim about therapeutic efficacy and clinical utility in the general population.
3. 3. BRIDGE GAP: There is a massive gap. The evidence is from 15 university students in a 2-week uncontrolled pilot. The conclusion is about replacing established clinical treatments across populations.
4. 4. RHETORICAL ANALYSIS: The company uses promotional language ('revolutionize,' 'replace clinical therapies') that actively sells clinical benefit and superiority. This is not cautious or hedged; it is a strong, unsupported claim.
5. 5. CAVEAT QUALITY: The university researchers correctly identify the fatal flaws (no control, small N, no long-term data). These caveats are accurate but are presented as afterthoughts, not as reasons to reject the company's claim.
6. 6. CLASSIFICATION DECISION: The primary forensic problem is not just the evidence-tier mismatch (which is severe) but the ACTIVE SELLING of clinical superiority ('replace clinical therapies') on the basis of a pilot study. This is rhetorical inflation — overclaim — not merely a cautious statement with a tier gap.

**Key Claims:**
- The company claims the app can 'revolutionize mental health care and replace clinical therapies' — this is a strong, unsupported therapeutic claim.
- The evidence is from a 2-week, uncontrolled pilot with 15 students and self-reported outcomes — insufficient to support any claim about clinical efficacy or therapeutic replacement.
- The university researchers correctly identify the lack of control group, small sample, and absence of long-term data — but these caveats do not appear to have stopped the company from making its strong claim.
- The 30% decline in subjective stress is not validated by objective measures, control conditions, or long-term follow-up, making it impossible to distinguish from placebo or regression to the mean.

**Alternative Hypotheses:**
- mechanism_vs_evidence: If the company had said 'the app shows promise and warrants further study' with the same caveats, the tier gap would be the main issue, and the classification would be mechanism_vs_evidence. But the company goes further and claims therapeutic replacement, which is active selling.
- solid: If the company had presented the pilot as preliminary and explicitly stated that clinical trials are needed before any therapeutic claims, this could be borderline solid (with caveats). But it does not; it makes a strong claim.

**Uncertainties:**
- Whether the 30% decline in subjective stress is real or entirely due to placebo/expectancy (no control group makes this unknowable)
- Whether the company's statement is a direct quote or a paraphrase; if paraphrased, the tone may be slightly different
- Whether the university researchers' caveats were part of the same press release or a separate critical response (the text suggests they are part of the same report, which is good)
- Whether there are any unpublished follow-up studies or longer-term data not mentioned in this summary

**Self-Verification:**
- Did I overstate the problems? No — the lack of a control group in a 2-week pilot is a genuine, fatal flaw for any claim about clinical efficacy. The company's claim to 'replace clinical therapies' is genuinely unsupported.
- Did I miss the possibility that this is solid? No — a 2-week uncontrolled pilot with 15 students cannot support claims about therapeutic replacement, even with hedging.
- Did I correctly distinguish overclaim from mechanism_vs_evidence? Yes — the company is actively selling clinical superiority ('replace clinical therapies'), not just implying potential. This is rhetorical inflation, not just a tier gap.
- Are the university researchers' caveats sufficient to make this solid? No — caveats are present but do not prevent the company from making the strong claim. The caveats are accurate but ineffective at stopping the overclaim.
- Did I assume the 30% decline is real? I noted it is self-reported and unvalidated, which is appropriate. I did not assume it is false, only that it cannot be attributed to the app without a control group.

**Dimension Scores:**
- Correctness: 30.0/30 `##########`
- Support Strength: 2.4/8 `###.......`
- Structural Reasoning: 5.3/8 `######....`
- Assumption Discipline: 4.2/6 `#######...`
- Uncertainty Handling: 3.6/6 `######....`
- Alternative Hypothesis Quality: 6.0/6 `##########`
- Self Monitoring Quality: 5.6/8 `#######...`
- Insight Depth: 8.0/8 `##########`
- Mechanism Quality: 1.5/10 `#.........`
- Communication Efficiency: 8.5/10 `########..`


## Final Verdict

**Solo run: Claude Haiku** scored **75.1/100**.

**Best per dimension:**
- Correctness: Claude Haiku (30.0/30)
- Support Strength: Claude Haiku (2.4/8)
- Structural Reasoning: Claude Haiku (5.3/8)
- Assumption Discipline: Claude Haiku (4.2/6)
- Uncertainty Handling: Claude Haiku (3.6/6)
- Alternative Hypothesis Quality: Claude Haiku (6.0/6)
- Self Monitoring Quality: Claude Haiku (5.6/8)
- Insight Depth: Claude Haiku (8.0/8)
- Mechanism Quality: Claude Haiku (1.5/10)
- Communication Efficiency: Claude Haiku (8.5/10)

**Latency vs Quality:**

| Agent | Latency | Score | Points/sec |
|-------|---------|-------|------------|
| Claude Haiku | 16.1s | 75.1/100 | 4.7 |

Failure modes observed: decorative_uncertainty, missed_key_insight, named_not_explained.
